Cell Sorting Market Size will be valued at USD 0.251 Billion in 2022. The Cell Sorting market industry is projected to grow from USD 0.271 Billion in 2023 to USD 0.501 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.00% during the forecast period (2024 - 2032).
The expanding applications of cell sorting technology across various fields, including research, clinical diagnostics, and biopharmaceutical production, arethe key market drivers improving the market growth.
Source: The Primary Research, Secondary Research, MRFR Database and Analyst Review
The market CAGR for cell sorting is being driven by the expanding applications of cell sorting technology across various fields. The expanding applications of cell sorting technology across research, clinical diagnostics, and biopharmaceutical production, coupled with technological advancements and a supportive regulatory environment, are key drivers fueling the growth of the cell sorting market. As the demand for precise and efficient cell analysis and manipulation tools continues to rise, the cell sorting market is poised for further expansion and innovation.
In research, cell sorting enables scientists to isolate and study rare cell populations, such as stem cells, circulating tumor cells, or immune cells, with high precision and efficiency. This capability has revolutionized fields such as immunology, oncology, neuroscience, and regenerative medicine. Researchers utilize cell sorting to investigate disease mechanisms, identify biomarkers, and develop novel therapeutics. Further, in clinical diagnostics, cell sorting plays a crucial role in disease diagnosis, prognosis, and monitoring. For instance, in cancer diagnostics, cell sorting enables the isolation and characterization of the circulating tumor cells (CTCs) from patient blood samples, providing valuable information for early cancer detection, treatment response assessment, and disease monitoring. Furthermore, cell sorting technologies are utilized in clinical immunology laboratories for analyzing immune cell subsets and diagnosing immunodeficiency disorders, autoimmune diseases, and infectious diseases. The growing demand for precise and reliable diagnostic tools, coupled with advancements in cell sorting technologies, is driving the expansion of the clinical cell sorting market.
In the biopharmaceutical industry, cell sorting is integral to the development and production of biologics, including monoclonal antibodies, cell-based therapies, and vaccines. Cell sorting enables the isolation and purification of specific cell types for downstream applications, such as cell culture, gene editing, and functional assays. This enhances the efficiency of bioprocesses, improves product quality, and accelerates the development timelines for biopharmaceutical products. Moreover, as the biopharmaceutical industry continues to focus on personalized medicine and targeted therapeutics, there is a growing need for cell-sorting technologies. Technological advancements are driving innovation and growth in the cell sorting market. Recent developments in flow cytometry, including the introduction of high-speed cell sorters with enhanced sensitivity, multiparametric analysis capabilities, and automation features, have expanded the utility and throughput of cell sorting platforms.
Furthermore, surging investment in research and development activities, collaborations between academic institutions and industry players, and rising government funding for life sciences research are contributing to the growth of the cell sorting market. These initiatives drive innovation, support technological advancements, and foster the commercialization of new cell-sorting products and applications. Thus, driving the Cell Sorting market revenue.
The Cell Sorting market segmentation, based on product, includes Instruments, Consumables, and Reagents. In 2023, the instruments segment dominated the market due to their pivotal role in facilitating precise and efficient isolation and analysis of specific cell populations. Flow cytometers and cell sorters are essential instruments utilized in research laboratories, clinical settings, and biopharmaceutical production facilities for a wide range of applications, including immunophenotyping, rare cell detection, and cell-based assays. Further, consumables and reagents have a significant growth as they are essential components of cell sorting workflows, comprising antibodies, buffers, dyes, and disposable sample containers.
The Cell Sorting market segmentation, based on application, includes Research Applications and Clinical Applications. In 2023, the research application dominated the market due to the widespread use of cell sorting technology in advancing scientific understanding across various disciplines. Researchers rely on cell sorting to isolate specific cell populations for in-depth analysis, enabling investigations into cellular heterogeneity, disease mechanisms, and therapeutic targets. The versatility and precision of cell sorting platforms make them indispensable tools for advancing basic research in fields such as immunology, oncology, neuroscience, and stem cell biology. Further, the clinical application segment is foreseen to grow significantly by providing essential tools for diagnosing diseases, monitoring treatment responses, and enabling personalized medicine approaches.
The Cell Sorting market segmentation, based on end users, includes Hospitals & Clinical Testing Laboratories, Pharmaceutical & Biotechnology Companies, and Others. In 2023, the pharmaceutical & biotechnology company category dominated the market due to their extensive utilization of advanced cell sorting technologies in drug discovery, development, and production processes. These companies rely on cell sorting platforms for isolating specific cell populations for research purposes, screening potential drug candidates, and optimizing bioproduction workflows. Their substantial investments in cutting-edge cell sorting technologies drive innovation and fuel market growth. Further, the hospitals & clinical testing laboratories segment is foreseen to have significant growth due to the increased adoption of advanced diagnostic and research tools in healthcare facilities.
Figure 1: Cell Sorting Market, by End User, 2023 & 2032 (USD Billion)
Source: The Primary Research, Secondary Research, MRFR Database and Analyst Review
By region, the study gives market insights into North America, Europe, Asia-Pacific, and the Rest of the World. The North American Cell Sorting market area will dominate this market, owing to the robust presence of pharmaceutical and biotechnology companies conducting cutting-edge research and drug development, coupled with substantial investments in healthcare infrastructure and life sciences research.
Further, the primary countries studied in the market report are the US, Canada, Germany, France, the UK, Italy, Spain, China, India, Australia, Japan, and South Korea.
Figure 2: Cell Sorting Market Share By Region 2023 (USD Billion)
Source: The Primary Research, Secondary Research, MRFR Database and Analyst Review
Europe's Cell Sorting market accounts for the second-largest market share due to the increasing emphasis on precision medicine initiatives and rising funding for life sciences research. Further, the German Cell Sorting market held the largest market share, and the UK Cell Sorting market was the fastest-growing market in the European region.
The Asia-Pacific Cell Sorting Market is expected to grow at the fastest CAGR from 2024 to 2032. This is due to the increasing adoption of cell sorting technologies in research institutions, clinical laboratories, and biotechnology companies. Moreover, China’s Cell Sorting market held the largest market share, and the Indian Cell Sorting market was the quickest-growing market in Asia-Pacific region.
Leading market players are investing heavily in research and development in order to expand their product lines, which will help the Cell Sorting market grow even more. Market participants are also undertaking different strategic activities to grow their footprint, with important market developments including new product launches, higher investments, contractual agreements, mergers and acquisitions, and collaboration with other organizations. To expand and sustain in a more competitive and surging market climate, the Cell Sorting industry must offer cost-effective items.
Manufacturing locally to lessen operational costs is one of the prime business tactics used by manufacturers in the cell sorting industry to benefit clients and improve the market sector. In recent years, the Cell Sorting industry has provided some of the most significant advantages to medicine. Major players in the Cell Sorting market, including Becton, Dickinson and Company, Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., Sony Biotechnology Inc., MiltenyiBiotec GmbH, Affymetrix, Inc., SysmexPartec GmbH, On-Chip Biotechnologies Co., Ltd., Cytonome/St, LLC, Union Biometrica, Inc, and others, are trying to grow market demand by investing in the research and development operations.
Bio-Rad Laboratories, Inc. is the leader in providing innovative products and solutions for the life science and clinical diagnostics markets. Headquartered in Hercules, California, the company offers a diverse portfolio of products, including instruments, reagents, software, and consumables, serving researchers, healthcare professionals, and biopharmaceutical companies worldwide. With a rich history spanning over six decades, Bio-Rad is renowned for its contributions to scientific discovery and advancements in areas such as genomics, proteomics, cell biology, and food safety testing. The company's commitment to quality, reliability, and customer satisfaction has attained it a reputation as a trusted partner in the life sciences community. In April 2020, Bio-Rad Laboratories Inc. acquired Celsee Inc., a company that provides consumables and instruments for the isolation, detection, and analysis of single cells. This acquisition helped the company to enhance its product portfolio in the field of single cell analysis.
Miltenyi Biotec is an international biotechnology company headquartered in Bergisch Gladbach, Germany, with a focus on providing products and services for cell biology research, immunology, and cellular therapy. Founded in 1989 by Stefan Miltenyi, the company is renowned for its innovative solutions in cell separation, cell analysis, and cell culture, including magnetic cell separation systems such as MACS Technology. Miltenyi Biotec's products are widely used in academic research, clinical trials, and pharmaceutical development, facilitating advancements in areas such as cancer immunotherapy, regenerative medicine, and infectious disease research. In January 2020, A groundbreaking GMP-compliant cell sorting system was launched by Miltenyi Biotec, making an industry milestone. This advanced technology adheres to GMP, ensuring a high level of precision and compliance in cell sorting processes.
Key Companies in the Cell Sorting Market Include
Becton, Dickinson, and Company
Bio-Rad Laboratories, Inc.
Sony Biotechnology Inc.
MiltenyiBiotec GmbH
Affymetrix, Inc.
SysmexPartec GmbH
On-Chip Biotechnologies Co., Ltd.
Cytonome/St, LLC
Union Biometrica, Inc,
Cell Sorting Industry Developments
May 2023:A leading medical technology company, Becton, Dickinson, and Company announced the worldwide commercial launch of BD FACSDiscover S8 Sorter to compile spectral flow cytometry with real-time imaging technology that helps researchers uncover more detailed information about cells that was previously invisible in traditional flow cytometry experiments.
August 2021:The world leader in serving science, Thermo Fisher Scientific Inc., acquired cell sorting technology assets from Propel Labs, a completely owned subsidiary of SIDIS Corp, helping the company expand its product portfolio.
June 2020:PHC Corporation collaborated with On-Chip Biotechnologies Co. Ltd to improve cell culturing solutions and offer comprehensive solutions for researchers and organizations.
Instruments
Consumables and Reagents
Research Application
Clinical Application
Hospitals & Clinical Testing Laboratories
Pharmaceutical & Biotechnology Companies
Others
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
South Korea
Australia
Rest of Asia-Pacific
Rest of the World
Middle East
Africa
Latin America
| Report Attribute/Metric | Details |
| Market Size 2022 | USD 0.251 Billion |
| Market Size 2023 | USD 0.271 Billion |
| Market Size 2032 | USD 0.501 Billion |
| Compound Annual Growth Rate (CAGR) | 8.00% (2024-2032) |
| Base Year | 2023 |
| Market Forecast Period | 2024-2032 |
| Historical Data | 2019- 2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, The Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Product, Application, End User, and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and the Rest of the World |
| Countries Covered | The US, Canada, Germany, France, UK, Italy, Spain, China, India, Japan, Australia, South Korea |
| Key Companies Profiled | Becton, Dickinson and Company, Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., Sony Biotechnology Inc., MiltenyiBiotec GmbH, Affymetrix, Inc., SysmexPartec GmbH, On-Chip Biotechnologies Co., Ltd., Cytonome/St, LLC, Union Biometrica, Inc. |
| Key Market Opportunities | Development of integrated multi-parameter sorting platforms capable of simultaneously analyzing and sorting cells based on multiple characteristics. |
| Key Market Dynamics | Increased demand for high-throughput and multiparametric analysis capabilities. |
Frequently Asked Questions (FAQ) :
The Cell Sorting market size was valued at USD 0.271 Billion in 2023.
The market is envisioned to rise at a CAGR of 8.00% during the forecast period 2024-2032.
North America had the largest share of the market.
The prime participants in the market are Becton, Dickinson and Company, Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., Sony Biotechnology Inc., MiltenyiBiotec GmbH, Affymetrix, Inc., SysmexPartec GmbH, On-Chip Biotechnologies Co., Ltd., Cytonome/St, LLC, Union Biometrica, Inc., and others.
The instrument category dominated the market in 2023.
The research application had the largest share in the market.
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
